When Josephine Hathcock of Newark, Delaware, went in for gallbladder surgery, she never dreamed she'd wake up an ovarian cancer patient. Neither did her doctors, who found the cancer accidentally while she was on the operating table. To make matters worse, the cancer was stage 3, aggressive and had spread to her abdomen.
It's Saturday night. Three young women are dressed to the nines at a trendy bistro on Rush Street in downtown Chicago. They're having drinks outside on the kind of summer night that makes you fall in love with the city.
We received hundreds of questions from you for The Clinic live Webcast, hosted by Dr Sanjay Gupta on August 23. Here are the best questions and the all important answers from our panel of cancer experts.
Women who use hormone therapy after menopause may be at a higher risk of ovarian cancer, and the risk remains elevated for up to two years after women stop taking estrogen, a new study says.
Myriad Genetics, a Utah-based company, vowed Wednesday to "vigorously defend" itself against a legal challenge to its patents on two human genes linked to breast and ovarian cancers, its attorney told CNN.
The first child in Britain known to have been screened as an embryo to ensure she did not carry a cancer gene was born Friday, a spokesman for University College London told CNN.
The chances of surviving ovarian cancer appear to vary dramatically depending on the levels of two tumor proteins, suggesting that this type of cancer may have a more nuanced outlook than the grim statistics indicate.
Researchers at the University of Pennsylvania have zeroed in on a possible marker for ovarian cancer. The discovery of the marker, called TEM1 and found in the blood vessels surrounding the tumor, could lead to new screening and treatment options.
When Josephine Hathcock of Newark, Delaware, went in for gallbladder surgery, she never dreamed she'd wake up an ovarian cancer patient. Neither did her doctors, who found the cancer accidentally while she was on the operating table. To make matters worse, the cancer was stage 3, aggressive and had spread to her abdomen.
It's Saturday night. Three young women are dressed to the nines at a trendy bistro on Rush Street in downtown Chicago. They're having drinks outside on the kind of summer night that makes you fall in love with the city.
We received hundreds of questions from you for The Clinic live Webcast, hosted by Dr Sanjay Gupta on August 23. Here are the best questions and the all important answers from our panel of cancer experts.
Women who use hormone therapy after menopause may be at a higher risk of ovarian cancer, and the risk remains elevated for up to two years after women stop taking estrogen, a new study says.
Myriad Genetics, a Utah-based company, vowed Wednesday to "vigorously defend" itself against a legal challenge to its patents on two human genes linked to breast and ovarian cancers, its attorney told CNN.
The first child in Britain known to have been screened as an embryo to ensure she did not carry a cancer gene was born Friday, a spokesman for University College London told CNN.
The chances of surviving ovarian cancer appear to vary dramatically depending on the levels of two tumor proteins, suggesting that this type of cancer may have a more nuanced outlook than the grim statistics indicate.
Researchers at the University of Pennsylvania have zeroed in on a possible marker for ovarian cancer. The discovery of the marker, called TEM1 and found in the blood vessels surrounding the tumor, could lead to new screening and treatment options.
What's scarier than mad cow disease? Nothing, really -- except illnesses that are 10 billion times more likely to hurt you. Think about it this way: Your risk of getting mad cow is much lower than your odds of winning the Powerball lottery. In short, it's not likely to happen. What could happen? In her lifetime, the average woman has a 1 in 2 chance of developing osteoporosis and a 1 in 3 chance of heart disease.
She was diagnosed with breast cancer in 2001, melanoma in 2002, ovarian cancer in 2004, and a recurrence, in the liver, in 2006. Yet for all her health travails, something else turned out to be Pat...
Recently ousted Hewlett-Packard chairwoman Patricia Dunn has been advised she should begin medical treatment for a recurrence of advanced ovarian cancer, according to two published reports.
If we told you that your tax dollars were going to a suave D.C. lawyer and a motorcycle freak, you'd be steamed. But if we added that Peter Levine and Ben Hitt of Correlogic Systems invented an ear...
Remember the great taxol debate? In the late 1980s, scientists established that the substance--found in the bark of the Pacific yew tree--was effective in treating ovarian cancer. Demand exploded (...
IT'S EXOTIC: a cancer drug made from the bark of a yew tree that grows only in a few areas of the Pacific Northwest and gives shelter to the rare northern spotted owl. It's one of the most expensiv...
The page you requested cannot be found. The page you are looking for might have been removed, had its name changed, or is temporarily unavailable.
Please try the following:
• If you typed the page address in the Address bar, make sure that it is spelled correctly.
• Open the edition.cnn.com home page and look for links to the information you want.
• Use the navigation bar above to find the link you are looking for.
• Click the Back button to try another link.
• Enter a term in the search form below to look for information on CNN sites or the Internet.
Video
